`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 1 of 7 PagelD# 28801
`
`EXHIBIT E
`EXHIBIT E
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 2 of 7 PageID# 28802
`
`
`
`UNITED STATES
`INTERNATIONAL TRADE COMMISSION
`
`------------------------------x
`
`In the Matter of Investigation No.
`
`
`
`CERTAIN TOBACCO HEATING ARTICLES 337-TA-1199
`
`AND COMPONENTS THEREOF
`
`------------------------------x
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pages:
`
`Place:
`
`Date:
`
`1396 through 1603
`Washington, D.C.
`February 1, 2021
`
`
`
`
`
`
`HERITAGE REPORTING CORPORATION
`Official Reporters
`1220 L Street, N.W., Suite 206
`Washington, D.C. 20005
`(202) 628-4888
`contracts@hrccourtreporters.com
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 3 of 7 PageID# 28803
`
`
`
`
` 1396
`
`
` 1 UNITED STATES INTERNATIONAL TRADE COMMISSION
`
` 2 Washington, D.C.
`
` 3 Before the Honorable Clark S. Cheney
`
` 4 Administrative Law Judge
`
` 5
`
` 6 ------------------------------x
`
` 7 In the Matter of Investigation No.
`
` 8
`
` 9 CERTAIN TOBACCO HEATING ARTICLES 337-TA-1199
`
` 10 AND COMPONENTS THEREOF
`
` 11 ------------------------------x
`
` 12
`
` 13
`
` 14
`
` 15
`
` 16 Monday, February 1, 2021
`
` 17
`
` 18 EVIDENTIARY HEARING - VOLUME VI - REMOTE
`
` 19
`
` 20
`
` 21 The parties met, via remote videoconferencing, pursuant to
`
` 22 notice of the Administrative Law Judge, at 9:00 a.m.
`
` 23 Eastern.
`
` 24
`
` 25 Reported by: Karen Brynteson, RMR, CRR, FAPR
`
`
`
`
`
`
`Heritage Reporting Corporation
`(202) 628-4888
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 4 of 7 PageID# 28804
`
`
`
` 1403
`
`
` 1 JUDGE CHENEY: Please proceed, Mr. Grant.
`
` 2 MR. GRANT: Thank you, Judge.
`
` 3 DIRECT EXAMINATION
`
` 4 BY MR. GRANT:
`
` 5 Q. Can you please introduce yourself to the Judge
`
` 6 and tell him what you do?
`
` 7 A. Yes. Good morning, Judge Cheney. My name is
`
` 8 Stacy Ehrlich. I'm a partner at the law firm of
`
` 9 Kleinfield, Kaplan & Becker in Washington, D.C., where I've
`
` 10 practiced for the last 25 years.
`
` 11 Q. And where did you go to law school?
`
` 12 A. I went to Harvard Law School.
`
` 13 Q. Can you tell the Judge what sort of law you
`
` 14 practice?
`
` 15 A. Sure. My expertise and -- and that of my firm
`
` 16 is -- is FDA regulatory law for the most part. I also do
`
` 17 some Federal Trade Commission advertising law, and for the
`
` 18 last decade or so, a large percentage of my practice has
`
` 19 focused on tobacco and nicotine products.
`
` 20 Q. Okay. Now, have you worked on any of these
`
` 21 tobacco substantial equivalence applications that we've
`
` 22 heard a lot about?
`
` 23 A. Yes. Since 2011, I've worked on at least 100
`
` 24 substantial equivalence reports, at least dozens of which
`
` 25 have been authorized by FDA.
`
`
`
`
`
`
`Heritage Reporting Corporation
`(202) 628-4888
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 5 of 7 PageID# 28805
`
`
`
` 1404
`
`
` 1 Q. Okay. And we've heard a lot of talk about
`
` 2 PMTAs. Have you advised on any of those?
`
` 3 A. Yeah, I would say I've advised on at least 15
`
` 4 PMTAs, and one -- one of -- most are still pending, but one
`
` 5 has been authorized.
`
` 6 Q. Okay. And I think we heard that -- from
`
` 7 Mr. Clissold that he hadn't worked on any MRTPAs, and from
`
` 8 Ms. Gilchrist, they're fairly rare. Have you worked on any
`
` 9 of those?
`
` 10 A. Yes. In fact, I have worked on one MRTP that
`
` 11 has been authorized by FDA.
`
` 12 Q. Okay. Have you been recognized by any outside
`
` 13 organizations for your work in FDA law?
`
` 14 A. Yes, for example, I routinely am recognized in
`
` 15 the Best Lawyers of America and Super Lawyers for FDA law.
`
` 16 Q. Okay. And outside of your practice and your
`
` 17 client work, can you describe your professional involvement
`
` 18 in FDA regulatory issues relating to tobacco products?
`
` 19 A. Sure, I speak and write very frequently on these
`
` 20 issues. I also served a term on the Board of Directors of
`
` 21 the Food & Drug Law Institute, and I'm currently serving my
`
` 22 second term on the FDL I Tobacco and Nicotine Products
`
` 23 Committee.
`
` 24 MR. GRANT: Your Honor, at this time, we would
`
` 25 tender Ms. Ehrlich as an expert in the field of FDA law and
`
`
`
`
`
`
`Heritage Reporting Corporation
`(202) 628-4888
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 6 of 7 PageID# 28806
`
`
`
` 1416
`
`
` 1 A. Yeah, the judge focused a lot on that issue. It
`
` 2 found that there was an epidemic-level rise in -- in youth
`
` 3 use of e-cigarettes, and it observed that this was a clear
`
` 4 public health crisis.
`
` 5 Q. Okay. In light of those findings, what did the
`
` 6 judge order in the case?
`
` 7 A. So the judge ordered that all applications
`
` 8 needed to be submitted by September 9th, 2020, and for
`
` 9 timely filed PMTAs, they could stay on the market while FDA
`
` 10 reviewed any pending PMTAs for up to one year.
`
` 11 Q. Okay. Per the court's order, when does that
`
` 12 one-year grace period begin?
`
` 13 A. The -- the beginning of that one-year grace
`
` 14 period is -- is the -- the application's filing.
`
` 15 Q. Okay. Does the FDA's sort of discretionary
`
` 16 level of enforcement impact in any way the status of
`
` 17 products that are sold that are not in compliance with the
`
` 18 Maryland District Court's order as being either lawful or
`
` 19 unlawful?
`
` 20 A. No. All -- like I said, all e-cigarette
`
` 21 products are illegal products. And those that are not
`
` 22 covered by the Maryland court's enforcement discretion
`
` 23 policy are subject to immediate enforcement and -- and are
`
` 24 not permitted on the market.
`
` 25 Q. Now, we had some witnesses testify that the
`
`
`
`
`
`
`Heritage Reporting Corporation
`(202) 628-4888
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 1017-5 Filed 02/11/22 Page 7 of 7 PageID# 28807
`
`
`
` 1477
`
`
` 1 JUDGE CHENEY: So no -- so no one-year period is
`
` 2 applicable to IQOS; is that -- am I picking that up
`
` 3 correctly?
`
` 4 THE WITNESS: Right. Well, IQOS is authorized.
`
` 5 So it would -- it wouldn't matter anyway. The one-year
`
` 6 period is only for products that are required to be
`
` 7 authorized and have not obtained authorization.
`
` 8 So -- so that -- but also IQOS is not considered
`
` 9 deemed product. So for many reasons, it doesn't apply to
`
` 10 IQOS.
`
` 11 JUDGE CHENEY: Is it your expert opinion that
`
` 12 the Vuse products are being sold illegally?
`
` 13 THE WITNESS: Yes, they are illegal products.
`
` 14 JUDGE CHENEY: Is there a difference between
`
` 15 being marketed illegally and being sold illegally? And the
`
` 16 reason I ask that question, if it helps you understand it,
`
` 17 is whether the distinctions that some people are making in
`
` 18 this case have to do with marketing statements versus the
`
` 19 sale of the product?
`
` 20 THE WITNESS: Right, no, I mean -- I'm sorry.
`
` 21 JUDGE CHENEY: So to rephrase my question, does
`
` 22 the one-year period apply to marketing statements, sales of
`
` 23 products, or both?
`
` 24 THE WITNESS: So the product itself is illegal.
`
` 25 So any sales of the product would be illegal. I suppose if
`
`
`
`
`
`
`Heritage Reporting Corporation
`(202) 628-4888
`
`